Halozyme Therapeutics, Inc. (HALO) Financial Statements (2023 and Earlier)

Company Profile

Business Address 11388 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121-1345
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments741368120355469205108
Cash and cash equivalents119148120581696743
Short-term investments622220 29730013865
Receivables91985930221632
Inventory, net of allowances, customer advances and progress billings546129235159
Inventory546129235159
Prepaid expense  3082101
Other undisclosed current assets402830412121220
Total current assets:926555543428510257172
Noncurrent Assets
Operating lease, right-of-use asset2  
Property, plant and equipment711117444
Restricted cash and investments1111111
Deferred income tax assets155  
Other undisclosed noncurrent assets1314114606
Total noncurrent assets:17825221210510
TOTAL ASSETS:1,104580566440520262182
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26226254483231
Accounts payable2264844
Accrued liabilities24205650402927
Deferred revenue22 
Debt893972092771722
Deferred revenue and credits4759
Other undisclosed current liabilities  4    
Total current liabilities:117421861491315562
Noncurrent Liabilities
Long-term debt and lease obligation787 383    
Long-term debt, excluding current maturities787 383    
Liabilities, other than long-term debt3757554048
Deferred revenue and credits5544044
Deferred revenue341
Other liabilities1342104
Total noncurrent liabilities:79073887554048
Total liabilities:90742947415618695111
Stockholders' equity
Stockholders' equity attributable to parent19715192249208(32)43
Common stock0000000
Additional paid in capital256625695780731553526
Accumulated other comprehensive income (loss)(1)00(0)(0)(0)(0)
Accumulated deficit(59)(475)(604)(531)(522)(585)(483)
Total stockholders' equity:19715192249208(32)43
Other undisclosed liabilities and equity   3512519928
TOTAL LIABILITIES AND EQUITY:1,104580566440520262182

Income Statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues443268196152317147135
Revenue, net152317147135
Cost of revenue
(Cost of Goods and Services Sold)
(81)(43)(46)(10)(31)(33)(29)
Gross profit:362224150142285113106
Operating expenses(86)(80)(218)(211)(204)(197)(133)
Operating income (loss):276144(68)(69)81(83)(27)
Nonoperating income1578310
Investment income, nonoperating     10
Other nonoperating income15783  
Interest and debt expense(28)(20)(12)(18)(22)(20)(5)
Income (loss) from continuing operations before equity method investments, income taxes:249129(73)(80)62(102)(32)
Other undisclosed income from continuing operations before income taxes  00   
Income (loss) from continuing operations before income taxes:249129(72)(80)62(102)(32)
Income tax expense (benefit)154(0)0(1)1(1) 
Net income (loss) available to common stockholders, diluted:403129(72)(80)63(103)(32)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):403129(72)(80)63(103)(32)
Other comprehensive income (loss)0(0)0(0)(0)0(0)
Comprehensive income (loss):403129(72)(80)63(103)(32)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)(0)10(0)  
Comprehensive income (loss), net of tax, attributable to parent:402129(72)(80)63(103)(32)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: